Literature DB >> 4322392

Studies on the deficiency of 21-hydroxylation in patients with congenital adrenal hyperplasia.

A P Simpoulos, J R Marshall, C S Delea, F C Bartter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4322392     DOI： 10.1210/jcem-32-3-438

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  5 in total

1.  Congenital adrenal hyperplasia: renin and steroid values during treatment.

Authors:  D B Grant; M J Dillon; S M Atherden; R J Levinsky
Journal:  Eur J Pediatr       Date:  1977-08-23       Impact factor: 3.183

Review 2.  Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a review of current knowledge.

Authors:  G E Bacon; R P Kelch
Journal:  J Endocrinol Invest       Date:  1979 Jan-Mar       Impact factor: 4.256

3.  Plasma 17-hydroxyprogesterone in newborn infants with congenital adrenal hyperplasia and in infants with normal adrenal function.

Authors:  S M Atherden; A T Edmunds; D B Grant
Journal:  Arch Dis Child       Date:  1974-03       Impact factor: 3.791

4.  Circadian variation in plasma 17-hydroxyprogesterone in patients with congenital adrenal hyperplasia.

Authors:  S M Atherden; N D Barnes; D B Grant
Journal:  Arch Dis Child       Date:  1972-08       Impact factor: 3.791

5.  Neonatal screening for 21-hydroxylase deficiency: a microfilter paper method for 17-alpha-hydroxyprogesterone assay.

Authors:  S Piazzi; M Capelli; M Paolini; D Perugini; G Grossi; A Balsamo; P Salomoni; A Cassio; G Bugiardini; E Cacciari
Journal:  J Endocrinol Invest       Date:  1982 Mar-Apr       Impact factor: 4.256
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.